Literature DB >> 3209991

Antibodies to HTLV-I in populations of the southwestern Pacific.

D M Asher1, J Goudsmit, K L Pomeroy, R M Garruto, M Bakker, S G Ono, N Elliot, K Harris, H Askins, Z Eldadah.   

Abstract

Sera collected from 1,102 individuals in 14 populations of the southwestern Pacific between 1956 and 1979 were tested by ELISA for antibodies to human T-cell leukemia virus type I (HTLV-I). Selected sera were also tested by particle agglutination and immunoblotting. Six of the populations had prevalences of antibodies greater than 4%, two populations had prevalences greater than 15%. Six populations had antibody prevalences of 2% or less. Three populations from the coast and northern islands of New Guinea had high prevalences of antibodies, while three New Guinea highland groups had virtually none. One population from the Solomon Islands had a high prevalence, while two others had very low prevalences. Two populations from small remote islands in Vanuatu both had high prevalences. Pacific sera did not neutralize a standard strain of virus readily neutralized by Japanese, European, and American sera. We conclude that infections with HTLV-I, some acquired more than 20 years ago, are widespread throughout the southwestern Pacific, even in several very isolated populations, although others have been spared. Some strains of HTLV-I in populations of the Pacific may have substantially different envelope proteins from prototype strains of America, Europe, and Japan.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3209991     DOI: 10.1002/jmv.1890260402

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  HTLV-I antibody studies in villagers in East Sepik Province, Papua New Guinea.

Authors:  R C Sanders; A Levin; G Anian; I Webber; H Lee; P Swanson; A Diwan; R Desowitz; W A Blattner; M P Alpers
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Seroepidemiological survey of HTLV-I infection in French Polynesia, Cook Islands and Fiji.

Authors:  E Chungue; J P Boutin; L Le Marchand; G Philippon; A Le Guellec; S Chanteau; J L Cartel; C Gras; P M Martin; J F Roux
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

3.  Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.

Authors:  R Mahieux; P Horal; P Mauclère; O Mercereau-Puijalon; M Guillotte; L Meertens; E Murphy; A Gessain
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

4.  Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea.

Authors:  M P Sherman; N K Saksena; D K Dube; R Yanagihara; B J Poiesz
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands.

Authors:  A Gessian; R Yanagihara; G Franchini; R M Garruto; C L Jenkins; A B Ajdukiewicz; R C Gallo; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

6.  Isolation of a human T-lymphotropic virus type I strain from Australian aboriginals.

Authors:  I Bastian; J Gardner; D Webb; I Gardner
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

7.  Characterization of a variant of human T-lymphotropic virus type I isolated from a healthy member of a remote, recently contacted group in Papua New Guinea.

Authors:  R Yanagihara; V R Nerurkar; R M Garruto; M A Miller; M E Leon-Monzon; C L Jenkins; R C Sanders; P P Liberski; M P Alpers; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

8.  Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum.

Authors:  R B Lal; D Rudolph; M P Alpers; A J Sulzer; Y P Shi; A A Lal
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

9.  Human T-cell leukemia virus type 1 molecular variants, Vanuatu, Melanesia.

Authors:  Olivier Cassar; Corinne Capuano; Laurent Meertens; Eliane Chungue; Antoine Gessain
Journal:  Emerg Infect Dis       Date:  2005-05       Impact factor: 6.883

10.  Verification of HTLV-I infection in the Solomon Islands by virus isolation and gene amplification.

Authors:  R Yanagihara; A B Ajdukiewicz; V R Nerurkar; R M Garruto; D C Gajdusek
Journal:  Jpn J Cancer Res       Date:  1991-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.